Which closed-end funds own Twist Bioscience Corp?
3 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $44.3K. Security type: common equity. Country: United States. CUSIP 90184D100 · ISIN US90184D1000 · ticker TWST.
Holdings are historical filings (report dates May 29, 2026 – Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| GUG Guggenheim Active Allocation Fund | U.S. Equity | 0.01% | $42.3K | 633 sh | $631M | 14.1% discount | May 29, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 0.00% | $1.7K | 17 sh | $690M | 3.5% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.00% | $206 | 2 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
3 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: TWIST BIOSCIENCE CORP.
Issuer-level search for “TWST” → · Compare two funds’ portfolios →